A unifying theory of atherogenesis

Medical Hypotheses

Volumn 47, Issue 4, 1996, Pages 321-325

  Sloop, G D ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VISCOSITY; ERYTHROCYTE AGGREGATION; HEMODYNAMICS; HUMAN; HYPOTHESIS; PRIORITY JOURNAL; REVIEW;

EID: 0029839415     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90073-0     Document Type: Article

References (35)

1. Gelin L-E, Kerstell J, Svanborg A. The effect of dietary fat on whole blood and plasma viscosity in normal and hypercholesterolemic subjects. In: Copley A L, ed. Hemorheology: Proceedings of the First International Conference. New York: Pergamon Press, 1968: 791-797.
2. de Simone G, Devereux R B, Chien S, Alderman M H, Atlas, S A, Laragh J H. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990; 81: 107-117
3. Linde T, Sandhagen B, Hagg A, Morlin C, Wikstrom B, Danielson B G. Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J Hypertens 1993; 11: 731-736.
4. Rogers M E, Williams D T, Niththyananthan R, Rampling M W, Heslop K E, Johnston D G. Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes. Clinical Science 1992; 82: 309-313.
5. Barnes A, Willars E. Diabetes. In: Chien S, Dormandy J, Ernst E, Matrai A, eds. Clinical Hemorheology. Boston, MA: Martinus Nijhoff, 1987: 791-797.
6. Dintenfass L. Rheology of Blood in Diagnostic and Preventive Medicine. Boston, M A: Butterworths, 1976: 249.
7. Yarnell J Y G, Baker I A, Seetnam P M et al. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease - the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844.
8. Chien S, Usami S, Dellenback R J, Gregerson M I. Influence of fibrinogen and globulins on blood rheology at low shear rates: comparison among elephant, dog, and man. In: Hartert H H, Copley A L, eds. Theoretical and Clinical Hemorheology - Proceedings of the Second International Conference. New York: Springer-Verlag, 1971: 144-153.
9. Lowe G D O. Blood viscosity, lipoproteins, and cardiovascular risk. Circulation 1992; 85: 2329-2331.
10. Fanari P, Somazzi R, Nasrawi F et al. Haemorheological changes in obese adolescents after short-term diet. Intern J Obesity 1993; 17: 487-494.
11. Bonithon-Kopp C, Levenson J, Scarabin P-Y et al. Longitudinal associations between plasma viscosity and cardiovascular risk factors in a middle-aged French population. Atherosclerosis 1993; 104: 173-182.
12. Ross R. The pathogenesis of atherosclerosis - an update. New Engl J Med 1986; 314: 488-500.
13. Gibson C M, Diaz L, Kandarpa K et al. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arteriosclerosis and Thrombosis 1993; 13: 310-315.
14. Ku D N, Giddens D P. Pulsatile flow in a model carotid bifurcation. Atherosclerosis 1983; 3: 31-39.
15. Holman R L, McGill H C, Strong J P, Geer J C. The natural history of atherosclerosis - the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol 1958; 34: 209-235.
16. Lowe G D O. Blood rheology in arterial disease. Clin Sci 1986; 71: 137-146.
17. Frangos J A, Eskin S G, McIntire L V. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985; 227: 1477-1479.
18. Fuster V, Bowie E J W, Lewis J C, Pass D N, Owen Jr C A, Brown A I. Resistance to arteriosclerosis in pigs with von Willebrand's disease. J Clin Invest 1978; 61: 722-730.
19. Pick R, Chediak J, Glick G. Aspirin inhibits development of coronary atherosclerosis in cynomolgus monkeys (Macaca fascicularis) fed an atherogenic diet. J Clin Invest 1979; 63: 158-162.
20. Koster J K, Tryka A F, H'Doubler P, Collins Jr J J. The effect of low-dose aspirin and dipyridamole upon atherosclerosis in the rabbit. Artery 1981; 9: 405-413.
21. Stary H C, Chandler A B, Dinsmore R E et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 1995; 15: 1512-1531.
22. Falk E, Fernandez-Ortiz A. Role of thrombosis in atherosclerosis and its complication. Am J Cardiol 1995; 75: 5B-11B.
23. Schwartz C J, Valente A J, Sprague E A, Kelly J L, Nerem R M. The pathogenesis of atherosclerosis: an overview. Clin Cardiol 1991; 14 (suppl I): I-1-16.
24. Silverman D I, Ginsburg G S, Pasternak R C. High-density lipoprotein subfraction. Am J Med 1993; 94: 636-645.
25. Illingworth D R. Lipoprotein metabolism. Am J Kidney Dis 1993; 22(1): 90-97.
26. Gordon D J, Rifkind B M. High-density lipoprotein - the clinical implication of recent studies. New Engl J Med 1989; 321: 1311-1316.
27. Sloop G D, Garber D W. Opposite effects of HDL and LDL on blood viscosity (abstract). The Fourth Saratoga International Conference on Atherosclerosis, February, 1996, Hawaii, USA.
28. Richter W O, Jacob B G, Ritter M M, Suhler K, Vierneisel K, Schwandt P. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 1993; 42(7): 888-894.
29. Jandl J H. Blood: Textbook of Hematology. Boston: Little, Brown, 1987: 39.
30. Hui D Y, Harmony J A K. Interactions of plasma lipoproteins with erythrocytes. I. Alteration of erythrocyte morphology. Biochim Biophys Acta 1979; 550: 407-424.
31. Ruhenstroth-Bauer G, Porz P, Boss N, Lehmacher W, Stamm D. The erythrocyte aggregation value (AW) as a measure of the risk of myocardial infarction and arteriosclerosis of peripheral arteries. Clin Cardiol 1985; 8: 529-534.
32. MacRury S M, Lennie S E, McColl P, Balendra R, MacCuish A D, Lowe G D O. Increased red cell aggregation in diabetes mellitus: association with cardiovascular risk factors. Diab Med 1993; 19: 21-26.
33. Ruhenstroth-Bauer G, Mossmer J, Ottl J, Koenig-Erich S, Heinemann G. Highly significant negative correlations between erythrocyte aggregation value and serum concentration of high density lipoprotein cholesterol in a sample from a normal population and in patients with coronary heart disease. Eur J Clin Invest 1987; 17: 275-279.
34. Bachorick P S, Levy R I, Rifkind BM. Lipids and dyslipoproteinemia. In: Henry J B, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia, P A: W B Saunders, 1991: 189.
35. Freis E D, Heath W C. Hydrodynamics of aortic blood flow. Circulation Research 1964; 14: 105-116.